Shanghai Yizhong Pharmaceutical Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000050F4
CNY
57.42
3.37 (6.23%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Poor long term growth as Net Sales has grown by an annual rate of 196.91% and Operating profit at 48.07% over the last 5 years

 
2

The company has declared Negative results for the last 5 consecutive quarters

3

With ROE of 0.29%, it has a very expensive valuation with a 8.35 Price to Book Value

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CNY 11,013 Million (Large Cap)

stock-summary
P/E

2,847.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.33

stock-summary
Return on Equity

4.42%

stock-summary
Price to Book

7.70

Revenue and Profits:
Net Sales:
74 Million
(Quarterly Results - Dec 2025)
Net Profit:
13 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
20.1%
0%
20.1%
6 Months
-1.8%
0%
-1.8%
1 Year
43.73%
0%
43.73%
2 Years
69.65%
0%
69.65%
3 Years
-6.51%
0%
-6.51%
4 Years
106.87%
0%
106.87%
5 Years
0%
0%
0.0%

Shanghai Yizhong Pharmaceutical Co., Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
196.91%
EBIT Growth (5y)
48.07%
EBIT to Interest (avg)
80.83
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.43
Sales to Capital Employed (avg)
0.18
Tax Ratio
39.09%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
32.26%
ROE (avg)
7.02%

Valuation key factors

Factor
Value
P/E Ratio
2847
Industry P/E
Price to Book Value
8.35
EV to EBIT
-972.78
EV to EBITDA
11520.41
EV to Capital Employed
13.06
EV to Sales
54.64
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-1.34%
ROE (Latest)
0.29%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -10.75% vs -7.28% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 6.30% vs -46.64% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "73.90",
          "val2": "82.80",
          "chgp": "-10.75%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "11.70",
          "val2": "4.10",
          "chgp": "185.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.90",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "13.50",
          "val2": "12.70",
          "chgp": "6.30%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "158.10%",
          "val2": "48.90%",
          "chgp": "10.92%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 83.83% vs -51.95% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 815.71% vs -95.67% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "317.10",
          "val2": "172.50",
          "chgp": "83.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "62.10",
          "val2": "-4.10",
          "chgp": "1,614.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.80",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "2.80",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "64.10",
          "val2": "7.00",
          "chgp": "815.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "195.80%",
          "val2": "-92.80%",
          "chgp": "28.86%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQstock-summary

Dec'25
Sep'25
Change(%)
Net Sales
73.90
82.80
-10.75%
Operating Profit (PBDIT) excl Other Income
11.70
4.10
185.37%
Interest
0.00
0.00
Exceptional Items
0.00
0.90
-100.00%
Consolidate Net Profit
13.50
12.70
6.30%
Operating Profit Margin (Excl OI)
158.10%
48.90%
10.92%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is -10.75% vs -7.28% in Sep 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is 6.30% vs -46.64% in Sep 2025

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
317.10
172.50
83.83%
Operating Profit (PBDIT) excl Other Income
62.10
-4.10
1,614.63%
Interest
0.00
0.80
-100.00%
Exceptional Items
0.00
2.80
-100.00%
Consolidate Net Profit
64.10
7.00
815.71%
Operating Profit Margin (Excl OI)
195.80%
-92.80%
28.86%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is 83.83% vs -51.95% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 815.71% vs -95.67% in Dec 2024

stock-summaryCompany CV
About Shanghai Yizhong Pharmaceutical Co., Ltd. stock-summary
stock-summary
Shanghai Yizhong Pharmaceutical Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available